Behanna HA - Search Results

1

Coassembly of amphiphiles with opposite peptide polarities into nanofibers.

Behanna HA, Donners JJ, Gordon AC, Stupp SI. Behanna HA, et al. J Am Chem Soc. 2005 Feb 2;127(4):1193-200. doi: 10.1021/ja044863u. J Am Chem Soc. 2005. PMID: 15669858

2

Synthesis of stilbene carboxylic acids as scaffolds for calcium sensors.

Behanna HA, Stupp SI. Behanna HA, et al. Chem Commun (Camb). 2005 Oct 14;(38):4845-7. doi: 10.1039/b506423f. Epub 2005 Aug 30. Chem Commun (Camb). 2005. PMID: 16193134

3

Modulation of fluorescence through coassembly of molecules in organic nanostructures.

Behanna HA, Rajangam K, Stupp SI. Behanna HA, et al. J Am Chem Soc. 2007 Jan 17;129(2):321-7. doi: 10.1021/ja062415b. J Am Chem Soc. 2007. PMID: 17212411

4

Supramolecular fluorophores for biological studies: phenylene vinylene-amino acid amphiphiles.

Harrington DA, Behanna HA, Tew GN, Claussen RC, Stupp SI. Harrington DA, et al. Among authors: behanna ha. Chem Biol. 2005 Oct;12(10):1085-91. doi: 10.1016/j.chembiol.2005.07.010. Chem Biol. 2005. PMID: 16242651

5

Heparin binding nanostructures to promote growth of blood vessels.

Rajangam K, Behanna HA, Hui MJ, Han X, Hulvat JF, Lomasney JW, Stupp SI. Rajangam K, et al. Among authors: behanna ha. Nano Lett. 2006 Sep;6(9):2086-90. doi: 10.1021/nl0613555. Nano Lett. 2006. PMID: 16968030

6

De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disorders.

Wing LK, Behanna HA, Van Eldik LJ, Watterson DM, Ralay Ranaivo H. Wing LK, et al. Among authors: behanna ha. Curr Alzheimer Res. 2006 Jul;3(3):205-14. doi: 10.2174/156720506777632844. Curr Alzheimer Res. 2006. PMID: 16842097 Review.

7

Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits.

Hu W, Ralay Ranaivo H, Roy SM, Behanna HA, Wing LK, Munoz L, Guo L, Van Eldik LJ, Watterson DM. Hu W, et al. Among authors: behanna ha. Bioorg Med Chem Lett. 2007 Jan 15;17(2):414-8. doi: 10.1016/j.bmcl.2006.10.028. Epub 2006 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 17079143 Free PMC article.

8

Molecular properties and CYP2D6 substrates: central nervous system therapeutics case study and pattern analysis of a substrate database.

Chico LK, Behanna HA, Hu W, Zhong G, Roy SM, Watterson DM. Chico LK, et al. Among authors: behanna ha. Drug Metab Dispos. 2009 Nov;37(11):2204-11. doi: 10.1124/dmd.109.028134. Epub 2009 Aug 6. Drug Metab Dispos. 2009. PMID: 19661215 Free PMC article.

9

Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.

Van Eldik LJ, Thompson WL, Ralay Ranaivo H, Behanna HA, Martin Watterson D. Van Eldik LJ, et al. Among authors: behanna ha. Int Rev Neurobiol. 2007;82:277-96. doi: 10.1016/S0074-7742(07)82015-0. Int Rev Neurobiol. 2007. PMID: 17678967 Review.

10

Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.

Karpus WJ, Reynolds N, Behanna HA, Van Eldik LJ, Watterson DM. Karpus WJ, et al. Among authors: behanna ha. J Neuroimmunol. 2008 Oct 15;203(1):73-8. doi: 10.1016/j.jneuroim.2008.06.039. J Neuroimmunol. 2008. PMID: 18678415 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters